Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 946 AL 960

Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer's disease

Zhang Y, Wang Y, Shi C, Shen M, Lu F.

Transl Neurodegener. 2021 Feb 1;10(1):6. doi: 10.1186/s40035-021-00230-9.

New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease

Guzman-Martinez L, Calfío C, Farias GA, Vilches C, Prieto R, Maccioni RB.

J Alzheimers Dis. 2021;82(s1):S51-S63. doi: 10.3233/JAD-201059.

Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses

Zhuang QS, Meng L, Wang Z, Shen L, Ji HF.

J Alzheimers Dis. 2021;80(1):271-281. doi: 10.3233/JAD-201235.

The synaptic marker neurogranin as a disease state biomarker in Alzheimer's disease: a systematic review and meta-analysis

Wang Z, Yang J, Zhu W, Tang Y, Jia J.

Int J Neurosci. 2022 Dec;132(12):1245-1253. doi: 10.1080/00207454.2021.1881087. Epub 2021 Feb 10.

Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases

Campese N, Palermo G, Del Gamba C, Beatino MF, Galgani A, Belli E, Del Prete E, Della Vecchia A, Vergallo A, Siciliano G, Ceravolo R, Hampel H, Baldacci F.

Expert Rev Proteomics. 2021 Jan;18(1):27-48. doi: 10.1080/14789450.2021.1886929. Epub 2021 Mar 7.

Clinical validity of increased cortical uptake of [(18)F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework

Wolters EE, Dodich A, Boccardi M, Corre J, Drzezga A, Hansson O, Nordberg A, Frisoni GB, Garibotto V, Ossenkoppele R.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2097-2109. doi: 10.1007/s00259-020-05118-w. Epub 2021 Feb 6.

Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

Rostamzadeh A, Schwegler C, Gil-Navarro S, Rosende-Roca M, Romotzky V, Ortega G, Canabate P, Moreno M, Schmitz-Luhn B, Boada M, Jessen F, Woopen C.

J Alzheimers Dis. 2021;80(2):601-617. doi: 10.3233/JAD-200484.

The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects

Chalkias E, Topouzis F, Tegos T, Tsolaki M.

J Alzheimers Dis. 2021;80(2):493-504. doi: 10.3233/JAD-201516.

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification

Izzo NJ, Yuede CM, LaBarbera KM, Limegrover CS, Rehak C, Yurko R, Waybright L, Look G, Rishton G, Safferstein H, Hamby ME, Williams C, Sadlek K, Edwards HM, Davis CS, Grundman M, Schneider LS, DeKosky ST, Chelsky D, Pike I, Henstridge C, Blennow K, Zetterberg H, LeVine H 3rd, Spires-Jones TL, Cirrito JR, Catalano SM.

Alzheimers Dement. 2021 Aug;17(8):1365-1382. doi: 10.1002/alz.12302. Epub 2021 Feb 8.

What have we learned from cognition in the oldest-old

Kawas CH, Legdeur N, Corrada MM.

Curr Opin Neurol. 2021 Apr 1;34(2):258-265. doi: 10.1097/WCO.0000000000000910.

Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting

Kokkinou M, Beishon LC, Smailagic N, Noel-Storr AH, Hyde C, Ukoumunne O, Worrall RE, Hayen A, Desai M, Ashok AH, Paul EJ, Georgopoulou A, Casoli T, Quinn TJ, Ritchie CW.

Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD010945. doi: 10.1002/14651858.CD010945.pub2.

Epigenetics of Alzheimer's Disease

Nikolac Perkovic M, Videtic Paska A, Konjevod M, Kouter K, Svob Strac D, Nedic Erjavec G, Pivac N.

Biomolecules. 2021 Jan 30;11(2):195. doi: 10.3390/biom11020195.

A narrative review on the potential of tomato and lycopene for the prevention of Alzheimer's disease and other dementias

Ratto F, Franchini F, Musicco M, Caruso G, Di Santo SG.

Crit Rev Food Sci Nutr. 2022;62(18):4970-4981. doi: 10.1080/10408398.2021.1880363. Epub 2021 Feb 12.

The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: A systematic review of the prediction of brain amyloid status

Ashford MT, Veitch DP, Neuhaus J, Nosheny RL, Tosun D, Weiner MW.

Alzheimers Dement. 2021 May;17(5):866-887. doi: 10.1002/alz.12253. Epub 2021 Feb 13.

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Bischof GN, Dodich A, Boccardi M, van Eimeren T, Festari C, Barthel H, Hansson O, Nordberg A, Ossenkoppele R, Sabri O, Giovanni BFG, Garibotto V, Drzezga A.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2110-2120. doi: 10.1007/s00259-020-05156-4. Epub 2021 Feb 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias